-
1 Comment
Nanosonics Limited is currently in a long term downtrend where the price is trading 16.1% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.6.
Nanosonics Limited's total revenue sank by 0.0% to $24M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $3M since the same quarter in the previous year.
Finally, its free cash flow fell by 123.6% to $-1M since the same quarter in the previous year.
Based on the above factors, Nanosonics Limited gets an overall score of 1/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | AU000000NAN9 |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Beta | 1.83 |
---|---|
PE Ratio | 83.33 |
Target Price | None |
Market Cap | 759M |
Dividend Yield | None |
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OQS.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025